Agios Pharmaceuticals AGIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$422.6M-2.4% | -$412.78M— | —— | —— | —— | ||
| $5.26M+1.6% | $5.18M-1.9% | $5.28M+0.6% | $5.25M-6.0% | $5.58M-1.2% | ||
| $56.73M+8.0% | $52.55M+6.5% | $49.33M+2.6% | $48.1M+7.0% | $44.97M+5.0% | ||
| -$380.41M-2.0% | -$372.98M+9.0% | -$409.93M-1.0% | -$406M-1.1% | -$401.46M-3.0% | ||
| $4.32M+0.1% | $4.32M+3.7% | $4.16M+37.5% | $3.03M+31.0% | $2.31M+37.1% | ||
| $405.91M+7.6% | $377.18M— | —— | —— | —— | ||
| $9.14M+5.3% | $8.68M-20.8% | $10.96M+19.6% | $9.16M-10.1% | $10.2M-29.4% | ||
| —— | —— | -$161.02M-4,315% | -$3.65M+90.8% | -$39.8M-233% | ||
| -$384.73M-2.0% | -$377.29M+8.9% | -$414.09M-1.2% | -$409.03M-1.3% | -$403.77M-3.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.